Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Vanda Pharmaceuticals

Clinical trials sponsored by Vanda Pharmaceuticals, explained in plain language.

Vanda Pharmaceuticals VNDA NASDAQ

Develops and commercializes therapies for central nervous system disorders.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 8 Not yet recruiting 1 Not yet finished but already full! 5 Completed 8 Terminated 3

New oral drug aims to tame ulcerative colitis Flare-Ups

Disease control Not yet recruiting

This trial tests whether the oral drug ponesimod can help people with moderately to severely active ulcerative colitis achieve remission. Participants receive either ponesimod or a placebo daily for 16 weeks, with an option to continue on ponesimod for another 36 weeks. The study…

Phase: PHASE3 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control

Last updated Jul 09, 2026 00:00 UTC